BA
The Boeing Company
BA has the edge over CXT overall, supported by stronger valuation and stronger fundamentals.
CXT
Crane NXT, Co.
CXT trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CXT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Under pressure |
CXT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CXT in the historical PE scenario, which offers more potential upside but is not a forecast.
CXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $56.99 | — |
| Cheap | 15x | $32.96 | -42% |
| Fair | 19x | $41.21 | -28% |
| Current | 26x | $56.99 | — |
| Expensive | 27x | $60.07 | +5.4% |
Historical ranges are pointers, not guarantees.
CXT's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CXT on the outlook, with more favorable profitability expectations.
CXT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CXT, but weaker profitability.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CXT on earnings, with more consistent year-over-year improvement.
CXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +108% |
| Q3 2026 | $2.20 | -18% |
| Q2 2026 | $2.41 | -8% |
| Q1 2026 | $2.23 | -23% |
| Q4 2025 | $2.50 | -22% |
| Q3 2025 | $2.68 | -12% |
| Q2 2025 | $2.62 | -17% |
| Q1 2025 | $2.91 | -8.2% |
| Q4 2022 | $2.43 | -4.7% |
CXT's earnings per share have fallen from their peak: $2.20 over the past year, against $3.31 in mid-2022.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $497.1M | +12% |
| Q2 2026 | $493.2M | +22% |
| Q1 2026 | $387.7M | +17% |
| Q4 2025 | $476.9M | +19% |
| Q3 2025 | $445.1M | +10% |
| Q2 2025 | $404.4M | +9.1% |
| Q1 2025 | $330.3M | +5.3% |
| Q4 2024 | $399.1M | +12% |
CXT's revenue has grown year over year for 10 quarters in a row: $497M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -5.2 points |
| Q2 2026 | 14% | +2.1 points |
| Q1 2026 | 5.7% | -5.6 points |
| Q4 2025 | 17% | -1 points |
| Q3 2025 | 18% | -0.2 points |
| Q2 2025 | 12% | -6.4 points |
| Q1 2025 | 11% | -6.4 points |
| Q4 2024 | 18% | -2.6 points |
CXT has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
CXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $90.2M | +15% |
| Q2 2026 | $73.4M | +32% |
| Q1 2026 | -$24.1M | +$8.1M |
| Q4 2025 | $96M | +37% |
| Q3 2025 | $78.7M | +47% |
| Q2 2025 | $55.8M | +16% |
| Q1 2025 | -$32.2M | -$29.2M |
| Q4 2024 | $70.3M | +11% |
CXT still generates free cash flow, though less than at its 2019 peak: $236M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.2% | +100K shares |
| 3 years | +1% | +600K shares |
| 5 years | -66% | -113M shares |
| Available history | -67% | -116M shares |
CXT has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
| Q2 2021 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CXT's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.5 | Neutral |
| Stochastic | 73.0 | Neutral |
CXT's weekly RSI is 61 (neutral) and its Stochastic is 73 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CXT on valuation relative to its sector.
CXT PE vs Industrials Sector
| Metric | CXT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 7.8% above |
| PE % | 82 | 58 | 24 pts above |
CXT is trading at 26x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.0 | 5.6% above |
| 20 week MA | $52.2 | 9.2% above |
| 50 week MA | $48.8 | 17% above |
| 100 week MA | $53.1 | 7.3% above |
| 200 week MA | $54.1 | 5.4% above |
CXT has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $26.7 | -11% |
| 2021 | $26.7 | $34.6 | +30% |
| 2022 | $34.6 | $34.6 | -0.2% |
| 2023 | $34.6 | $56.9 | +65% |
| 2024 | $56.9 | $58.0 | +2% |
| 2025 | $58.0 | $48.4 | -17% |
| 2026 YTD | $48.4 | $57.0 | +18% |
CXT has the edge over BA on returns for 2026, with the stronger performance.